vs
Side-by-side financial comparison of Globalstar, Inc. (GSAT) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Globalstar, Inc. is the larger business by last-quarter revenue ($72.0M vs $57.2M, roughly 1.3× Vanda Pharmaceuticals Inc.). Globalstar, Inc. runs the higher net margin — -16.1% vs -246.8%, a 230.6% gap on every dollar of revenue. On growth, Globalstar, Inc. posted the faster year-over-year revenue change (17.6% vs 7.6%). Over the past eight quarters, Globalstar, Inc.'s revenue compounded faster (12.9% CAGR vs 9.8%).
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
GSAT vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.0M | $57.2M |
| Net Profit | $-11.6M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | -0.5% | -70.5% |
| Net Margin | -16.1% | -246.8% |
| Revenue YoY | 17.6% | 7.6% |
| Net Profit YoY | 76.9% | -2774.3% |
| EPS (diluted) | $-0.11 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $72.0M | $57.2M | ||
| Q3 25 | $73.8M | $56.3M | ||
| Q2 25 | $67.1M | $52.6M | ||
| Q1 25 | $60.0M | $50.0M | ||
| Q4 24 | $61.2M | $53.2M | ||
| Q3 24 | $72.3M | $47.7M | ||
| Q2 24 | $60.4M | $50.5M | ||
| Q1 24 | $56.5M | $47.5M |
| Q4 25 | $-11.6M | $-141.2M | ||
| Q3 25 | $1.1M | $-22.6M | ||
| Q2 25 | $19.2M | $-27.2M | ||
| Q1 25 | $-17.3M | $-29.5M | ||
| Q4 24 | $-50.2M | $-4.9M | ||
| Q3 24 | $9.9M | $-5.3M | ||
| Q2 24 | $-9.7M | $-4.5M | ||
| Q1 24 | $-13.2M | $-4.1M |
| Q4 25 | -0.5% | -70.5% | ||
| Q3 25 | 13.8% | -55.6% | ||
| Q2 25 | 9.2% | -73.2% | ||
| Q1 25 | -14.2% | -82.0% | ||
| Q4 24 | -6.9% | -19.3% | ||
| Q3 24 | 13.0% | -23.1% | ||
| Q2 24 | -2.4% | -20.1% | ||
| Q1 24 | -8.3% | -19.5% |
| Q4 25 | -16.1% | -246.8% | ||
| Q3 25 | 1.5% | -40.1% | ||
| Q2 25 | 28.6% | -51.7% | ||
| Q1 25 | -28.9% | -58.9% | ||
| Q4 24 | -82.1% | -9.2% | ||
| Q3 24 | 13.7% | -11.2% | ||
| Q2 24 | -16.0% | -9.0% | ||
| Q1 24 | -23.4% | -8.7% |
| Q4 25 | $-0.11 | $-2.40 | ||
| Q3 25 | $-0.01 | $-0.38 | ||
| Q2 25 | $0.13 | $-0.46 | ||
| Q1 25 | $-0.16 | $-0.50 | ||
| Q4 24 | $-0.57 | $-0.09 | ||
| Q3 24 | $0.00 | $-0.09 | ||
| Q2 24 | $-0.01 | $-0.08 | ||
| Q1 24 | $-0.01 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $447.5M | $84.9M |
| Total DebtLower is stronger | $483.8M | — |
| Stockholders' EquityBook value | $355.7M | $327.2M |
| Total Assets | $2.3B | $488.9M |
| Debt / EquityLower = less leverage | 1.36× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $84.9M | ||
| Q3 25 | $346.3M | $70.0M | ||
| Q2 25 | $308.2M | $81.0M | ||
| Q1 25 | $241.4M | $111.8M | ||
| Q4 24 | $391.2M | $102.3M | ||
| Q3 24 | $51.9M | $100.5M | ||
| Q2 24 | $64.3M | $103.0M | ||
| Q1 24 | $59.3M | $125.2M |
| Q4 25 | $483.8M | — | ||
| Q3 25 | $508.6M | — | ||
| Q2 25 | $491.5M | — | ||
| Q1 25 | $502.7M | — | ||
| Q4 24 | $511.4M | — | ||
| Q3 24 | $394.4M | — | ||
| Q2 24 | $393.1M | — | ||
| Q1 24 | $398.7M | — |
| Q4 25 | $355.7M | $327.2M | ||
| Q3 25 | $364.8M | $466.0M | ||
| Q2 25 | $360.9M | $486.3M | ||
| Q1 25 | $344.3M | $511.4M | ||
| Q4 24 | $358.9M | $538.5M | ||
| Q3 24 | $394.1M | $541.2M | ||
| Q2 24 | $383.0M | $542.5M | ||
| Q1 24 | $377.1M | $544.0M |
| Q4 25 | $2.3B | $488.9M | ||
| Q3 25 | $2.2B | $601.1M | ||
| Q2 25 | $1.9B | $624.7M | ||
| Q1 25 | $1.7B | $631.9M | ||
| Q4 24 | $1.7B | $656.2M | ||
| Q3 24 | $917.6M | $645.1M | ||
| Q2 24 | $926.2M | $651.4M | ||
| Q1 24 | $917.0M | $652.7M |
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 1.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.9M | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-29.5M |
| FCF MarginFCF / Revenue | — | -51.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.9M | $-29.4M | ||
| Q3 25 | $236.0M | $-31.6M | ||
| Q2 25 | $157.9M | $-15.3M | ||
| Q1 25 | $51.9M | $-33.1M | ||
| Q4 24 | $340.7M | $-1.8M | ||
| Q3 24 | $32.0M | $-14.6M | ||
| Q2 24 | $36.7M | $-6.9M | ||
| Q1 24 | $29.8M | $7.6M |
| Q4 25 | — | $-29.5M | ||
| Q3 25 | — | $-31.8M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | — | $-33.6M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-14.7M | ||
| Q2 24 | — | $-7.0M | ||
| Q1 24 | — | $7.6M |
| Q4 25 | — | -51.6% | ||
| Q3 25 | — | -56.5% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -67.1% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -30.9% | ||
| Q2 24 | — | -13.9% | ||
| Q1 24 | — | 15.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 216.53× | — | ||
| Q2 25 | 8.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
